Curio Biotech Ltd developed cell-based screening platforms to evaluate anti-aging and senescence-modulating interventions using human-relevant cellular models.
Published
Signal category
Research & Knowledge
Quote
“We have developed cell-based screening platforms to evaluate anti-aging and senescence-modulating interventions using human-relevant cellular models.”
— Curio Biotech Ltd team
Company
Curio Biotech Ltd
A CRO providing personalized Life Science Research Services
- Industry
- Biotechnology Research
- Location
- Visp, CH
- Company size
- 4 employees
Established in January 2017, Curio Biotech Ltd is a science-based Contract Research Organization (CRO) providing human in vitro research services to its clients in the pharmaceutical, cosmetic and nutraceutical industries. It has provided specialized and customized human in vitro research services to clients across 3 continents. Curio Biotech’s core expertise is in primary human cells and 3D reconstructed tissue culture systems. These cell and tissue models are used for drug screening, toxicity and functional assays with small and large molecules. Our areas of expertise are human dermatology, immuno-oncology, vascular and stem cell biology, metabolism, inflammation and ageing. We have completed at least one or several projects in these areas. Curio Biotech is aligned with the 3R (Replace, Reduce, and Refine) principles and has developed new in vitro models.
Founded 2017